CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
OPERATING ACTIVITIES:
Net loss	$ (16,555)	$ (3,340)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Depreciation	10,779	13,054
Amortization, including accretion and write-off of deferred financing costs	4,544	4,440
Deferred income taxes	(3,491)	(7,004)
(Earnings) loss of equity method investee	(344)	329
Loss on sale of fixed assets	78	258
Share-based compensation expense	2,560	2,207
Excess tax deficiency related to share-based compensation expense	453	238
Changes in operating assets and liabilities:
Accounts receivable, net	(15,101)	(6,094)
Inventories, net	18,301	3,438
Prepaid expenses and other assets	(2,668)	(1,038)
Accounts payable	15,540	(849)
Accrued expenses and other liabilities	7,492	12,123
Net cash provided by operating activities	21,588	17,762
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(9,352)	(12,920)
Proceeds from sale of fixed assets	225	222
Investment in venture capital fund, net	(92)	(260)
Net cash used for investing activities	(9,219)	(12,958)
FINANCING ACTIVITIES:
Revolving credit facility borrowings	18,500	57,000
Revolving credit facility payments	(59,000)	(58,000)
Proceeds from issuance of debt	12,805	17,677
Repayments of debt	(13,366)	(17,690)
Repurchase of Common Shares to satisfy employee tax withholding	(302)	(666)
Net cash used for financing activities	(41,363)	(1,679)
Effect of exchange rate changes on cash and cash equivalents	6,934	(1,854)
Net change in cash and cash equivalents	(22,060)	1,271
Cash and cash equivalents at beginning of period	71,832	40,841
Cash and cash equivalents at end of period	49,772	42,112
Supplemental disclosure of cash flow information:
Cash paid for interest, net	6,708	8,003
Cash paid for income taxes, net	6,937	4,372
Capital expenditures included in accounts payable	$ 1,084	$ 479